TY  - JOUR
AU  - Bonora, Enzo
AU  - Frias, Juan P
AU  - Tinahones, Francisco J
AU  - Van, Joanna
AU  - Malik, Raleigh E
AU  - Yu, Zhuoxin
AU  - Mody, Reema
AU  - Bethel, Angelyn
AU  - Kwan, Anita Y M
AU  - Cox, David A
PY  - 2021
DO  - 10.1111/dom.14465
UR  - http://hdl.handle.net/10668/18058
T2  - Diabetes, obesity & metabolism
AB  - To evaluate the impact of dulaglutide 3.0 and 4.5 mg versus 1.5 mg on body weight in patients with type 2 diabetes (T2D) based on exploratory analyses of the AWARD-11 trial. Patients were randomized to once-weekly dulaglutide 1.5 (n = 612), 3.0...
LA  - en
KW  - dulaglutide
KW  - type 2 diabetes
KW  - weight
KW  - Diabetes Mellitus, Type 2
KW  - Glucagon-Like Peptides
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Immunoglobulin Fc Fragments
KW  - Middle Aged
KW  - Recombinant Fusion Proteins
TI  - Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD-11.
TY  - research article
VL  - 23
ER  -